A new publication involving corticorelin was released on October 23, 2026. The paper, titled "Neural circuitry mediating hypercapnia-induced microarousal and impaired sleep depth," appeared in the journal Science Advances.
This entry marks the publication date and venue as reported. No findings, conclusions, or data from the study are detailed here beyond the title and publication information provided.
Corticorelin remains an approved compound. Readers interested in the broader context of this compound, including its regulatory status and prior research, can consult the compound overview for additional background.